Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 86601 - 86620 out of 488862 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Canada | (L01XE01) imatinib | pms-Imatinib | Tab/Co. Orl 100 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | PMS |
Canada | (L01XE01) imatinib | pms-Imatinib | Tab/Co. Orl 400 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | PMS |
Canada | (L01XE01) imatinib | Teva-Imatinib | Tab/Co. Orl 100 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | TEV |
Canada | (L01XE01) imatinib | Teva-Imatinib | Tab/Co. Orl 400 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | TEV |
Canada | (L01XE06) dasatinib | Sprycel | Tab/Co. Orl 140 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRI |
Canada | (L01XE06) dasatinib | Sprycel | Tab/Co. Orl 20 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRI |
Canada | (L01XE06) dasatinib | Sprycel | Tab/Co. Orl 50 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRI |
Canada | (L01XE06) dasatinib | Sprycel | Tab/Co. Orl 70 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRI |
Canada | (L01XE06) dasatinib | Sprycel | Tab/Co. Orl 80 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRI |
Canada | (L01XE06) dasatinib | Sprycel | Tab/Co. Orl 100 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRI |
Canada | (L01XE07) lapatinib | Tykerb | Tab/Co. Orl 250 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NVR |
Canada | (L01XE14) bosutinib | Bosulif | Tab/Co. Orl 100 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | PFI |
Canada | (L01XE14) bosutinib | Bosulif | Tab/Co. Orl 500 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | PFI |
Canada | (L01XE24) ponatinib | Iclusig | Tab/Co. Orl 15 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid; Leukemia, Lymphoid | TAK |
Canada | (L01XE24) ponatinib | Iclusig | Tab/Co. Orl 45 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid; Leukemia, Lymphoid | TAK |
Canada | (L01XE26) cabozantinib | Cabometyx | Tab/Co. Orl 20 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Carcinomas, Hepatocellular | IPS |
Canada | (L01XE26) cabozantinib | Cabometyx | Tab/Co. Orl 40 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Carcinomas, Hepatocellular | IPS |
Canada | (L01XE26) cabozantinib | Cabometyx | Tab/Co. Orl 60 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Carcinomas, Hepatocellular | IPS |
Canada | (L01XE28) ceritinib | Zykadia | Cap/Caps Orl 150 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NVR |
Canada | (L01XE31) nintedanib | Ofev | Cap/Caps Orl 100 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis | BOE |